Cynosure Lutronic secures CE Mark for Mosaic 3D platform
February 2, 2026
The Mosaic 3D device incorporates several features designed to enhance safety and patient comfort.
The Mosaic 3D device incorporates several features designed to enhance safety and patient comfort.
GE HealthCare (Nasdaq: GEHC)+
announced today that it received FDA 510(k) clearance and CE mark for its Allia Moveo platform.
Medtronic (NYSE: MDT)+
today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery system.
Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions.
For people who are at high risk of developing breast cancer, frequent screenings with ultrasound can help detect tumors early.
Pink noise—often used to promote sleep—may reduce restorative REM sleep and interfere with sleep recovery. In contrast, earplugs were found to be significantly more effective in protecting sleep against traffic noise.
Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease.
As humans age beyond early adulthood, their physical and mental functions tend to slowly worsen over time. One of the most common sources of severe mental decline in older adults are neurodegenerative diseases, conditions characterized by the progressive loss of neurons in the brain or peripheral nervous system.
When a car accident or athletic injury destroys more than 20% of a muscle’s mass, the body faces a problem it often can’t heal fully on its own. Without intervention, scar tissue fills the injury site and can leave patients with permanent weakness and limited mobility.
Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ancestry, according to a new review study led by researchers from the University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) and the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).